The 2021 approval by regulatory agencies of belimumab, a B lymphocyte stimulator (BLyS) inhibitor, and the 2022 approval of anifrolumab, a type I interferon inhibitor, has increased the therapeutic ...
GLP-1 receptor agonists were originally developed for the treatment of type 2 diabetes, and later of obesity, but there is growing evidence that their benefits extend far beyond reductions in blood ...
Globally, the prevalence of adolescents experiencing symptoms of anxiety and depression has been rising steeply in the past two decades,1 and diagnoses continue to increase.2 Symptoms of anxiety and ...
During the 16th and 18th centuries, scurvy, a disease caused by insufficient vitamin C intake, affected millions of sailors due to scarcity of fruits and vegetables during long voyages. Three ...
Food systems are facing a global crisis. Most countries are falling behind rather than progressing toward achieving the seven global nutrition targets set for 2030,1 while unsustainable food ...
aDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium bDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium cDepartment of Biomedical Sciences, ...